Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93:102693.

Article  PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

PubMed  Google Scholar 

Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27:1345–56.

Article  CAS  PubMed  Google Scholar 

K Gokduman. Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes. Curr Drug Targets. 2016;17:1928–39.

Article  Google Scholar 

Molinaro M, Skrodzki D, Pan D. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024;16:e1984.

Article  CAS  PubMed  Google Scholar 

Shen G, Li S, Zhu Y, Xu Z, Liu X, Lv C, et al. Recent progress in topoisomerase inhibitors as anticancer agents: Research and design strategies for Topo I and II inhibitors via structural optimization. Bioorg Chem. 2025;165:109040.

Article  CAS  PubMed  Google Scholar 

Jang JY, Kim D, Im E, Kim ND. Etoposide as a Key Therapeutic Agent in Lung Cancer: Mechanisms, Efficacy, and Emerging Strategies. Int J Mol Sci. 2025;26:796.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi QR, Tian H, Yue BS, Zhai BT, Zhao F. Research Progress of SN38 Drug Delivery System in Cancer Treatment. Int J Nanomed. 2024;19:945–64.

Article  CAS  Google Scholar 

Yang XY, Zhao HY, Lei H, Yuan B, Mao S, Xin M, et al. Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity. ChemMedChem. 2021;16:1000–10.

Article  CAS  PubMed  Google Scholar 

Milano G, Innocenti F, Minami H. Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs. Cancer Sci. 2022;113:2224–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su Z, Li L, Hao F, Zhao J, Li M, Zhao X, et al. A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models. Pharm Res. 2023;40:3043–58.

Article  CAS  PubMed  Google Scholar 

Arslan FB, Öztürk K, Tavukçuoğlu E, Öztürk SC, Esendağlı G, Çalış S. A novel combination for the treatment of small cell lung cancer: Active targeted irinotecan and stattic co-loaded PLGA nanoparticles. Int J Pharm. 2023;632:122573.

Article  CAS  PubMed  Google Scholar 

García-Soriano D, Milán-Rois P, Lafuente-Gómez N, Rodríguez-Díaz C, Navío C, Somoza Á, et al. Multicore iron oxide nanoparticles for magnetic hyperthermia and combination therapy against cancer cells. J Colloid Interface Sci. 2024;670:73–85.

Article  PubMed  Google Scholar 

Chircov C, Petcu MC, Vasile BS, Purcăreanu B, Nicoară AI, Oprea OC, et al. Irinotecan-loaded magnetite-silica core-shell systems for colorectal cancer treatment. Int J Pharm. 2024;661:124420.

Article  CAS  PubMed  Google Scholar 

Gao F, Guo J, Liu S, Zhang F, Zhang Y, Wang L. Empowering hydrophobic anticancer drugs by ultrashort peptides: General Co-assembly strategy for improved solubility, targeted efficacy, and clinical application. J Colloid Interface Sci. 2024;667:119–27.

Article  CAS  PubMed  Google Scholar 

Weng W, Meng T, Zhao Q, Shen Y, Fu G, Shi J, et al. Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer. Cancer Discov. 2023;13:950–73.

Article  PubMed  Google Scholar 

Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, et al. Combination therapy in combating cancer. Oncotarget. 2017;8:38022–43.

Article  Google Scholar 

Reyes-Farias M, Carrasco-Pozo C. The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism. Int J Mol Sci. 2019;20:3177.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng H, Wei F, Han W, Li Y, Xu X, Zhang L, et al. Synergistic chemotherapy and immunomodulatory effects of Quercetin in cancer: a review. Front Immunol. 2025;16:1547992.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alam S, Mohammad T, Padder RA, Hassan MI, Husain M. Thymoquinone and quercetin induce enhanced apoptosis in non-small cell lung cancer in combination through the Bax/Bcl2 cascade. J Cell Biochem. 2022;123:259–74.

Article  CAS  PubMed  Google Scholar 

Yang P, Li X, Wen Q, Zhao X. Quercetin attenuates the proliferation of arsenic-related lung cancer cells via a caspase-dependent DNA damage signaling. Mol Carcinog. 2022;61:655–63.

Article  CAS  PubMed  Google Scholar 

Tang SM, Deng XT, Zhou J, Li QP, Ge XX, Miao L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121:109604.

Article  CAS  PubMed  Google Scholar 

Lotfi N, Yousefi Z, Golabi M, Khalilian P, Ghezelbash B, Montazeri M, et al. The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update. Front Immunol. 2023;14:1077531.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cabral H, Li JJ, Miyata K, Kataoka K. Controlling the biodistribution and clearance of nanomedicines. Nat Reviews Bioeng. 2024;2:214–32.

Article  CAS  Google Scholar 

Man FC, Tang J, Swedrowska M, Forbes B. R Rosales. Imaging drug delivery to the lungs: Methods and applications in oncology. Adv Drug Deliv Rev. 2023;192:114641.

Article  CAS  PubMed  Google Scholar 

Woodward IR, Fromen CA. Recent Developments in Aerosol Pulmonary Drug Delivery: New Technologies, New Cargos, and New Targets. Annu Rev Biomed Eng. 2024;26:307–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang B, Wang L, Yang Q, Zhang YM, Qinglai T, Yang XM, et al. Pulmonary inhalation for disease treatment: Basic research and clinical translations. Mater Today Bio. 2024;25:100966.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al Khatib AO, El-Tanani M, Al-Obaidi H. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics. 2023;15:2777.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong LH, Zhuang XM. Insights into Inhalation Drug Disposition: The Roles of Pulmonary Drug-Metabolizing Enzymes and Transporters. Int J Mol Sci. 2024;25:4671.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101–24.

Article  CAS  PubMed  Google Scholar 

Bardoliwala D, Javia A, Ghosh S, Misra A, Sawant K. Formulation and clinical perspectives of inhalation-based nanocarrier delivery: a new archetype in lung cancer treatment. Ther Deliv. 2021;12:397–418.

Article  CAS  PubMed